Royal Bank of Canada »

Turn Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Turn Therapeutics (TTRX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Turn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Turn Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turn Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $206k 28k 7.29

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Turn Therapeutics

Steel Peak Wealth Management
Ieq Capital
DDFG
Vanguard Capital Management
Wellington Shields & Co
Millennium Management
BlackRock
Aaron Wealth Advisors
Tamar Securities
Royal Bank of Canada
Bridgewater Advisors
Citadel Advisors
Brown Brothers Harriman & Co.
HighTower Advisors
RVW Wealth

View all funds holding Turn Therapeutics